美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Array Digital Infrastructure Inc.

49.46

+1.122.32%

盤後：49.460.00000.00%16:37 EDT

成交量：12.39萬

成交額：609.84萬

市值：42.72億

市盈率：89.11

高：49.54

開：48.24

低：48.24

收：48.34

52周最高：79.17

52周最低：44.03

股本：8,637.99萬

流通股本：1,506.76萬

量比：1.64

換手率：0.82%

股息：- -

股息率：- -

每股收益(TTM):0.5551

每股收益(LYR):0.5551

淨資產收益率：4.80%

總資產收益率：-0.41%

市淨率：1.66

市盈率(LYR):89.11

資料載入中...

總覽公司新聞資訊公告

Digitus集團簽署協議收購科威特Gulfsat公司

娃哈哈被曝大規模停產，「連AD鈣奶和營養快線都讓停了」，知情人回應

Apogee Therapeutics公布3.5億美元承銷公開發行定價

中泰證券：檢驗類立項指南征求意見稿印發創新檢測給予加收空間、AD標誌物檢測列項

陳天橋九年來首度受訪：歷史或以「ChatGPT前後」劃分，中美應在同一球隊

凤凰网科技

國內外藥企共同發力，大批新藥、新適應症同日獲批 / 申報！

美國OTC市場Leddartech Holdings Inc.盤中異動快速跳水12.00%

北京協和醫院發布阿爾茨海默病新藥數據，早期患者疾病進展有望放緩

歐亞經濟聯盟延長對華機動車彈簧片反傾銷税有效期

三生國健重組抗IL-4Rα人源化單抗申報上市

港股異動 | 中國抗體-B(03681)午前升逾5% 預計最早於二季度啓動針對SM17 AD的II期臨床試驗

康哲藥業(00867)：創新藥磷酸蘆可替尼乳膏增加特應性皮炎(AD)適應症中國上市許可申請獲受理並獲納入優先審評

美國OTC市場Leddartech Holdings Inc.股價拉升28.57% 市值漲2.91萬美元

美國OTC市場Leddartech Holdings Inc.股價飆升36.36% 市值漲4.11萬美元

美國OTC市場Leddartech Holdings Inc.盤中異動股價大漲20.00%報0.003美元

單分子AD血液檢測提交FDA審批！

IVD从业者网

希森美康簽約Fujirebio，拿下AD血檢產品代理！

IVD从业者网

釋放pipeline in a drug潛力 NLRP3能否催生下一個「藥王」?

智通财经网

美國OTC市場Leddartech Holdings Inc.盤中異動大幅上漲18.18%報0.003美元

Digitus集團關聯公司簽署1110萬第納爾銀行融資協議

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/AD/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AD\",,,,,undefined,":{"symbol":"AD","market":"US","secType":"STK","nameCN":"Array Digital Infrastructure Inc.","latestPrice":49.46,"timestamp":1776369600000,"preClose":48.34,"halted":0,"volume":123940,"hourTrading":{"tag":"盘后","latestPrice":49.46,"preClose":49.46,"latestTime":"16:37 EDT","volume":5325,"amount":263374.5,"timestamp":1776371872135,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.023169218038891132,"floatShares":15067629,"shares":86379877,"eps":0.555055,"marketStatus":"未開盤","change":1.12,"latestTime":"04-16 16:00:00 EDT","open":48.24,"high":49.54,"low":48.24,"amount":6098432.9968,"amplitude":0.026893,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.555055,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1776412800000},"marketStatusCode":0,"adr":0,"exchange":"NYSE","adjPreClose":48.34,"postHourTrading":{"tag":"盘后","latestPrice":49.46,"preClose":49.46,"latestTime":"16:37 EDT","volume":5325,"amount":263374.5,"timestamp":1776371872135,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.642686,"impliedVol":0.368,"impliedVolPercentile":0.7778},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AD\",,,,,undefined,":{"symbol":"AD","floatShares":15067629,"roa":"-0.41%","roe":"4.80%","lyrEps":0.555055,"volumeRatio":1.642686,"shares":86379877,"dividePrice":0,"high":49.54,"amplitude":0.026893,"preClose":48.34,"low":48.24,"week52Low":44.03,"pbRate":"1.66","psRate":"26.22","week52High":79.165,"institutionHeld":0.3323,"latestPrice":49.46,"eps":0.555055,"divideRate":0,"volume":123940,"delay":0,"ttmEps":0.555055,"open":48.24,"prevYearClose":53.62,"prevWeekClose":49.44,"prevMonthClose":46.14,"prevQuarterClose":46.14,"fiveDayClose":49.36,"twentyDayClose":46.52,"sixtyDayClose":56.55,"dividendPayoutRate":40.52599213795753,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.4274298457535774},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-20","symbol":"AD","fiscalQuarterEnding":"2025/12","expectedEps":0.32,"name":null,"time":"盤前","type":"earning","dateTimestamp":1771563600000,"reportTimeType":"pre","actualEps":0.48},{"date":"2026-01-23","symbol":"AD","amount":10.25,"announcedDate":"2026-01-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-23","defaultRemindTime":1769178600000,"name":"Array Digital Infrastructure Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-02","payableDate":"2026-01-23","currency":"USD","dateTimestamp":1769144400000,"payDate":"2026-02-02"},{"market":"US","date":"2025-11-07","symbol":"AD","fiscalQuarterEnding":"2025/09","expectedEps":0.25,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"pre","actualEps":0.97},{"date":"2025-08-20","symbol":"AD","amount":23,"announcedDate":"2025-08-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-11","defaultRemindTime":1755696600000,"name":"Array Digital Infrastructure Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-19","payableDate":"2025-08-11","currency":"USD","dateTimestamp":1755662400000,"payDate":"2025-08-19"},{"market":"US","date":"2025-08-11","symbol":"AD","fiscalQuarterEnding":"2025/06","expectedEps":0.33,"name":null,"time":"盤前","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":0.36}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AD\",market:\"US\",,,undefined,":[{"executeDate":"2025-08-20","recordDate":"2025-08-11","paymentDate":"2025-08-19","value":23,"currency":"USD"},{"executeDate":"2026-01-23","recordDate":"2026-01-23","paymentDate":"2026-02-02","value":10.25,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.6667,"hold":0.1667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1764129600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AD","date":"2026-04-15","current":87.973264,"percent":0.470238,"low":-273.92211,"twenty":-179.920448,"median":237.014074,"eighty":264.60628,"high":320.844562,"avg":76.081176,"sd":211.925614,"marketCap":4219280584},"quantilePoints":[{"date":"2025-08-15","current":-273.850129,"twenty":-273.893318,"median":-273.850129,"eighty":-273.612593,"marketCap":6572403103},{"date":"2025-08-22","current":-200.933798,"twenty":-273.763753,"median":-273.490226,"eighty":-228.502362,"marketCap":4822411161},{"date":"2025-08-29","current":-194.49692,"twenty":-273.591,"median":-200.933798,"eighty":-194.626488,"marketCap":4667926077},{"date":"2025-09-05","current":-189.890035,"twenty":-273.511821,"median":-195.360711,"eighty":-192.519268,"marketCap":4557360841},{"date":"2025-09-12","current":-184.671298,"twenty":-272.73443,"median":-194.119011,"eighty":-189.199003,"marketCap":4432111159},{"date":"2025-09-19","current":-175.349555,"twenty":-256.070925,"median":-192.368109,"eighty":-183.778715,"marketCap":4208389313},{"date":"2025-09-26","current":-169.950862,"twenty":-200.271577,"median":-189.74607,"eighty":-179.092649,"marketCap":4078820677},{"date":"2025-10-03","current":-180.892213,"twenty":-197.170296,"median":-184.671298,"eighty":-177.638601,"marketCap":4341413113},{"date":"2025-10-10","current":-180.028422,"twenty":-195.252737,"median":-184.059446,"eighty":-177.861746,"marketCap":4320682131},{"date":"2025-10-17","current":-179.200623,"twenty":-194.756057,"median":-183.555568,"eighty":-177.18511,"marketCap":4300814940},{"date":"2025-10-24","current":-177.581015,"twenty":-194.345757,"median":-180.586287,"eighty":-177.242697,"marketCap":4261944349},{"date":"2025-10-31","current":-176.105372,"twenty":-193.617663,"median":-180.892213,"eighty":-177.242697,"marketCap":4226528922},{"date":"2025-11-07","current":-171.642452,"twenty":-192.972746,"median":-180.010426,"eighty":-176.702827,"marketCap":4119418849},{"date":"2025-11-14","current":241.378582,"twenty":-192.09564,"median":-179.920448,"eighty":-175.407141,"marketCap":3917333000},{"date":"2025-11-21","current":240.473745,"twenty":-190.782619,"median":-179.452562,"eighty":-172.916544,"marketCap":3902648400},{"date":"2025-11-28","current":261.764027,"twenty":-189.890035,"median":-179.056658,"eighty":-170.850644,"marketCap":4248168400},{"date":"2025-12-05","current":265.117247,"twenty":-189.602105,"median":-178.588771,"eighty":240.420519,"marketCap":4302587800},{"date":"2025-12-12","current":265.543053,"twenty":-189.098227,"median":-177.958923,"eighty":244.409875,"marketCap":4309498200},{"date":"2025-12-19","current":274.059166,"twenty":-184.671298,"median":-177.329076,"eighty":249.043083,"marketCap":4447706200},{"date":"2025-12-26","current":286.620433,"twenty":-184.613712,"median":-177.149119,"eighty":260.390804,"marketCap":4651563000},{"date":"2026-01-02","current":285.396241,"twenty":-184.556126,"median":-176.681232,"eighty":261.913059,"marketCap":4631695600},{"date":"2026-01-09","current":277.199482,"twenty":-183.965869,"median":-175.78145,"eighty":263.648217,"marketCap":4498670400},{"date":"2026-01-16","current":297.372025,"twenty":-183.569965,"median":-174.161842,"eighty":266.266922,"marketCap":4826050600},{"date":"2026-01-23","current":320.844562,"twenty":-183.555568,"median":-173.981886,"eighty":271.994008,"marketCap":5206986400},{"date":"2026-01-30","current":252.1834,"twenty":-183.238845,"median":-172.02036,"eighty":268.321434,"marketCap":4092684400},{"date":"2026-02-06","current":257.665648,"twenty":-182.648588,"median":-169.950862,"eighty":267.224985,"marketCap":4181655800},{"date":"2026-02-13","current":269.109175,"twenty":-182.115917,"median":238.717297,"eighty":267.224985,"marketCap":4367372800},{"date":"2026-02-20","current":267.938209,"twenty":-181.48247,"median":240.926164,"eighty":268.704659,"marketCap":4348369200},{"date":"2026-02-27","current":255.643071,"twenty":-181.064971,"median":244.409875,"eighty":267.842403,"marketCap":4148831400},{"date":"2026-03-06","current":262.668864,"twenty":-180.769843,"median":247.365175,"eighty":267.342081,"marketCap":4262853000},{"date":"2026-03-13","current":255.643071,"twenty":-180.229973,"median":249.043083,"eighty":266.671437,"marketCap":4148831400},{"date":"2026-03-20","current":82.941723,"twenty":-180.021224,"median":248.376453,"eighty":265.819826,"marketCap":4043906649},{"date":"2026-03-27","current":82.498564,"twenty":-179.985233,"median":245.210832,"eighty":265.628214,"marketCap":4022299967},{"date":"2026-04-02","current":84.413012,"twenty":-179.95644,"median":244.199544,"eighty":265.543053,"marketCap":4115640834},{"date":"2026-04-10","current":87.513828,"twenty":-179.920448,"median":240.447132,"eighty":265.117247,"marketCap":4266824209},{"date":"2026-04-15","current":86.538694,"twenty":-179.920448,"median":237.014074,"eighty":264.60628,"marketCap":4219280584}],"updateTime":1776360001096},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AD\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1171376009","title":"Digitus集團簽署協議收購科威特Gulfsat公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1171376009","media":"投资观察","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171376009?lang=zh_tw&edition=fundamental","pubTime":"2026-04-08 17:01","pubTimestamp":1775638900,"startTime":"0","endTime":"0","summary":"迪吉特斯数字基建、数据中心与通信集团近日宣布，已正式签署收购科威特Gulfsat公司的协议。此次交易总价值达600万科威特第纳尔。\n该收购协议标志着Digitus集团在中东地区数字基础设施领域的战略布局取得重要进展。交易完成后，集团有望进一步拓展区域业务网络，强化数据中心与通信服务能力。\n（根据公开信息整理）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TDS","AD","BK4132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622837243","title":"娃哈哈被曝大規模停產，「連AD鈣奶和營養快線都讓停了」，知情人回應","url":"https://stock-news.laohu8.com/highlight/detail?id=2622837243","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622837243?lang=zh_tw&edition=fundamental","pubTime":"2026-03-28 15:56","pubTimestamp":1774684560,"startTime":"0","endTime":"0","summary":"　　3月27日，有媒体报道，娃哈哈于3月26日临时通知，停掉了70%的工厂生产线，其中包括娃哈哈、宏胜两方的多家工厂，恢复生产大概在4月2日。除生产红色娃哈哈瓶装水的工厂外，其他工厂几乎全部停产。　　3月27日下午，接近娃哈哈的人士向每日经济新闻记者透露，此次变化并非停工停产，而是正常排产调整。春节一般是快消旺季，此前春节期间娃哈哈备货较多，部分产品仍有一些库存积压，所以内部通过排产调整来调节。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-03-28/doc-inhspryw5787234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4132","AD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157135932","title":"Apogee Therapeutics公布3.5億美元承銷公開發行定價","url":"https://stock-news.laohu8.com/highlight/detail?id=1157135932","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157135932?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 09:55","pubTimestamp":1774403756,"startTime":"0","endTime":"0","summary":"旧金山和波士顿，2026年3月24日——临床阶段生物技术公司Apogee Therapeutics, Inc.今日宣布，其先前公布的承销公开发行已完成定价。此次发行以每股70.00美元的公开发行价格，共计发行5,000,000股普通股。在扣除承销折扣、佣金以及Apogee应承担的其他发行费用之前，公司预计从此次发行中获得的总收益约为3.5亿美元。此外，Apogee已授予承销商一项为期30天的选择权，允许其以公开发行价额外购买最多750,000股普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AD","BK4139","APGE","USA","BK4132","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619875163","title":"中泰證券：檢驗類立項指南征求意見稿印發 創新檢測給予加收空間、AD標誌物檢測列項","url":"https://stock-news.laohu8.com/highlight/detail?id=2619875163","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619875163?lang=zh_tw&edition=fundamental","pubTime":"2026-03-13 13:45","pubTimestamp":1773380711,"startTime":"0","endTime":"0","summary":"从结构上看，创新检测项目及新兴疾病标志物检测领域受益更为明确，其中AD血液生物标志物检测在本次指南中集中列项，为相关检测产品未来进入收费体系提供政策基础。本次立项指南明确相关检测项目价格框架，为各省后续制定具体收费标准提供依据，有望推动AD血液检测从“技术可行”向“临床可收费”转变，产业化路径进一步清晰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413499.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0276","AD","600918","BK4132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617505569","title":"陳天橋九年來首度受訪：歷史或以「ChatGPT前後」劃分，中美應在同一球隊","url":"https://stock-news.laohu8.com/highlight/detail?id=2617505569","media":"凤凰网科技","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617505569?lang=zh_tw&edition=fundamental","pubTime":"2026-03-06 09:43","pubTimestamp":1772761430,"startTime":"0","endTime":"0","summary":"AI无泡沫陈天桥还驳斥了AI行业目前存在泡沫的说法。陈天桥接受采访正值美中两国争夺全球AI主导权之际。他还开玩笑说，AI带来了如此巨大的变革，未来历史或许不再以公元前和公元后划分，而是以“ChatGPT之前”和“ChatGPT之后”来划分。“我们现在才刚刚进入‘ChatGPT后’的第三年，”他补充道，“AI的未来将是一段非常漫长的旅程。”","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8rGeBzxvpvx","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["BK4023","BK4017","LU0498741114.HKD","BK4585","BK4587","AIYY","BK4528","BK4588","AGI","BC","BK4551","BK4543","AI","BK4132","LU0498741890.SGD","LU0055631609.USD","AD","LU0368265764.SGD","BK4190","LU0496367417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616812581","title":"國內外藥企共同發力，大批新藥、新適應症同日獲批 / 申報！","url":"https://stock-news.laohu8.com/highlight/detail?id=2616812581","media":"制药网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616812581?lang=zh_tw&edition=fundamental","pubTime":"2026-03-04 14:33","pubTimestamp":1772606026,"startTime":"0","endTime":"0","summary":"2026年以来，国内已有多款1 类创新药、全球首创产品、新适应症获批上市，同时有多个重磅品种申报上市获受理，覆盖肿瘤、自身免疫、妇科、代谢等核心赛道。如在3月3日，诺和诺德、礼来、亚虹医药等多家药企就相继宣布新药/新适应症在国内申报上市，或获得了《药品注册证书》。截至目前，司美格鲁肽在中国已获批4项适应症。这是吡洛西利继联合氟维司群、单药治疗适应症获批后，在中国获批的第三个适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304143745a449f534&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304143745a449f534&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1223082196.USD","CDE","NVO","02575","AD","LU1223083913.SGD","BK4132","BK4017","LU1223082519.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616758310","title":"美國OTC市場Leddartech Holdings Inc.盤中異動 快速跳水12.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616758310","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616758310?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 23:17","pubTimestamp":1772464620,"startTime":"0","endTime":"0","summary":"北京时间2026年03月02日23时17分，美国OTC市场Leddartech Holdings Inc.股票出现异动，股价急速跳水12.00%。截至发稿，该股报0.006美元/股，成交量1139股，换手率0.00%，振幅0.00%。美国OTC市场Leddartech Holdings Inc.股票所在的软件服务行业中，整体涨幅为0.95%。美国OTC市场Leddartech Holdings Inc.公司简介：LeddarTech Holdings Inc 是一家开发和提供全面感知软件解决方案的公司，旨在支持高级驾驶辅助系统和自动驾驶应用的部署。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302231700a442ad1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302231700a442ad1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AD","BK4023","BK4132","LDTCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614009885","title":"北京協和醫院發布阿爾茨海默病新藥數據，早期患者疾病進展有望放緩","url":"https://stock-news.laohu8.com/highlight/detail?id=2614009885","media":"澎湃新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614009885?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 16:56","pubTimestamp":1772096160,"startTime":"0","endTime":"0","summary":"2月26日，澎湃新闻从北京协和医院获悉，北京协和医院发布了仑卡奈单抗治疗早期阿尔茨海默病的中国真实世界研究结果，早期AD患者的疾病进展速度有望放缓。北京协和医院自2024年7月起进行仑卡奈单抗的国内单中心真实世界研究，目前已纳入65例早期AD患者，通过神经心理学测试、脑部影像、血液检测等多维度评估疗效与安全性。高晶介绍，仑卡奈单抗的作用是延缓疾病进展，而非治愈AD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226165715a4cacdb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226165715a4cacdb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AD","BK4132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614006020","title":"歐亞經濟聯盟延長對華機動車彈簧片反傾銷税有效期","url":"https://stock-news.laohu8.com/highlight/detail?id=2614006020","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614006020?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 16:38","pubTimestamp":1772095135,"startTime":"0","endTime":"0","summary":"2019年9月2日，欧亚经济委员会对原产于中国的机动车弹簧片启动反倾销调查。2021年2月19日，欧亚经济委员会发布第2021/254/AD29号公告，对涉案产品征收为期五年的反倾销税，税率为14.11%，有效期至2026年3月20日。2025年11月18日，欧亚经济委员会对该案启动日落复审调查。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226163856a721a00a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226163856a721a00a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4132","AD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614009839","title":"三生國健重組抗IL-4Rα人源化單抗申報上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2614009839","media":"医药地理","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614009839?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 13:01","pubTimestamp":1772082100,"startTime":"0","endTime":"0","summary":"2月26日，国家药品监督管理局药品审评中心官网显示，三生国建自主研发的重组抗IL-4Rα人源化单克隆抗体注射液上市申请获受理，用于治疗外用药控制不佳或不适合外用药治疗的成人中重度特应性皮炎。过去30年，全球范围内AD患病率逐渐增加，我国成人患病率为6.1%。SSGJ-611是三生国建自主研发设计、筛选并人源化的抗IL-4Rα单克隆抗体，具有全新的氨基酸序列。SSGJ-611能够通过特异性的结合IL-4Rα，阻断IL-4和IL-13的信号传导达到缓解特应性皮炎等疾病的作用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226142431a7211c56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226142431a7211c56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDE","LU1223082196.USD","LU1223083913.SGD","LU1223082519.USD","BK4132","AD","BK4017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614277992","title":"港股異動 | 中國抗體-B(03681)午前升逾5% 預計最早於二季度啓動針對SM17 AD的II期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2614277992","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614277992?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 11:49","pubTimestamp":1771991346,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中国抗体-B午前涨超5%，截至发稿，涨4.48%，报2.1港元，成交额952.99万港元。消息面上，中国抗体-B发布公告，于2026年2月24日，公司同类首创治疗产品SM17用于治疗炎症性肠病患者的新药临床试验申请已获中国国家药品监督管理局批准。公司已完成针对使用SM17皮下注射剂型的健康志愿者I期桥接实验的随访。有关研究数据将用作支持IBD适应症的进展直接推进II期临床开发。公司预计最早于本年第二季度启动针对AD的II期临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407017.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","AD","03681","BK1161","BK4585","VXUS","BK1574","BK4132","VT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613871794","title":"康哲藥業(00867)：創新藥磷酸蘆可替尼乳膏增加特應性皮炎(AD)適應症中國上市許可申請獲受理並獲納入優先審評","url":"https://stock-news.laohu8.com/highlight/detail?id=2613871794","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613871794?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 17:49","pubTimestamp":1771926559,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业 发布公告，旗下德镁医药有限公司已于2026年2月24日获得中国国家药品监督管理局受理磷酸芦可替尼乳膏轻中度特应性皮炎的新药上市许可申请。且该项NDA因“符合儿童生理特征的儿童用药品新品种、剂型和规格”，已获得NMPA药品审评中心批准纳入优先审评品种名单，有望加快产品AD适应症上市审评进程。此次增加AD适应症NDA获受理，是产品向多治疗领域拓展的关键里程碑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406728.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159992","BK1574","SG9999015952.SGD","LU2488822045.USD","IE00BYV24P56.USD","00867","SG9999015978.USD","IE00BVYPNQ40.USD","SG9999015986.USD","SG9999015945.SGD","IE00BMCWC346.EUR","BK4132","IE00BGHQDM52.EUR","06978","SG9999004220.SGD","IE00BVYPNP33.GBP","AD","BK1161","BK1191","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613710454","title":"美國OTC市場Leddartech Holdings Inc.股價拉升28.57% 市值漲2.91萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613710454","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613710454?lang=zh_tw&edition=fundamental","pubTime":"2026-02-23 23:54","pubTimestamp":1771862062,"startTime":"0","endTime":"0","summary":"北京时间2026年02月23日23时54分，美国OTC市场Leddartech Holdings Inc.股票出现异动，股价急速上涨28.57%。截至发稿，该股报0.003美元/股，成交量10.514万股，换手率0.28%，振幅28.57%。美国OTC市场Leddartech Holdings Inc.股票所在的软件服务行业中，整体跌幅为3.28%。美国OTC市场Leddartech Holdings Inc.公司简介：LeddarTech Holdings Inc 是一家开发和提供全面感知软件解决方案的公司，旨在支持高级驾驶辅助系统和自动驾驶应用的部署。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223235422a4bf77f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223235422a4bf77f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LDTCF","AD","BK4023","BK4132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611819687","title":"美國OTC市場Leddartech Holdings Inc.股價飆升36.36% 市值漲4.11萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611819687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611819687?lang=zh_tw&edition=fundamental","pubTime":"2026-02-14 03:19","pubTimestamp":1771010341,"startTime":"0","endTime":"0","summary":"北京时间2026年02月14日03时19分，美国OTC市场Leddartech Holdings Inc.股票出现波动，股价快速上涨36.36%。截至发稿，该股报0.003美元/股，成交量114股，换手率0.00%，振幅0.00%。美国OTC市场Leddartech Holdings Inc.股票所在的软件服务行业中，整体涨幅为1.20%。美国OTC市场Leddartech Holdings Inc.公司简介：LeddarTech Holdings Inc 是一家开发和提供全面感知软件解决方案的公司，旨在支持高级驾驶辅助系统和自动驾驶应用的部署。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260214031901a6f8b9cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260214031901a6f8b9cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4132","AD","LDTCF","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610264325","title":"美國OTC市場Leddartech Holdings Inc.盤中異動 股價大漲20.00%報0.003美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610264325","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610264325?lang=zh_tw&edition=fundamental","pubTime":"2026-02-09 23:01","pubTimestamp":1770649260,"startTime":"0","endTime":"0","summary":"北京时间2026年02月09日23时01分，美国OTC市场Leddartech Holdings Inc.股票出现异动，股价大幅拉升20.00%。截至发稿，该股报0.003美元/股，成交量480股，换手率0.00%，振幅0.00%。美国OTC市场Leddartech Holdings Inc.股票所在的软件服务行业中，整体涨幅为1.37%。美国OTC市场Leddartech Holdings Inc.公司简介：LeddarTech Holdings Inc 是一家开发和提供全面感知软件解决方案的公司，旨在支持高级驾驶辅助系统和自动驾驶应用的部署。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209230100a6e6a26c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209230100a6e6a26c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LDTCF","BK4132","AD","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610250899","title":"單分子AD血液檢測提交FDA審批！","url":"https://stock-news.laohu8.com/highlight/detail?id=2610250899","media":"IVD从业者网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610250899?lang=zh_tw&edition=fundamental","pubTime":"2026-02-08 11:12","pubTimestamp":1770520348,"startTime":"0","endTime":"0","summary":"文章来源于IVD工具人，作者IVD工具人Quanterix于2026年2月3日宣布，已向美国食品药品监督管理局提交LucentADComplete多指标算法血液检测的510上市前通知。该产品此前已获得FDA突破性医疗器械认定。多指标+算法，指向AD血液检测的主流方向当前阿尔茨海默病诊断正在从侵入性腰椎穿刺及高成本PET影像，逐步向血液检测过渡。相较于单一生物标志物检测，LucentADComplete采用多指标联合与算法整合策略。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260208130734a48a2a28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260208130734a48a2a28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AD","BK4132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609547542","title":"希森美康簽約Fujirebio，拿下AD血檢產品代理！","url":"https://stock-news.laohu8.com/highlight/detail?id=2609547542","media":"IVD从业者网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609547542?lang=zh_tw&edition=fundamental","pubTime":"2026-02-07 14:48","pubTimestamp":1770446938,"startTime":"0","endTime":"0","summary":"纽约当地时间2月5日，希森美康宣布已与Fujirebio富士瑞必欧就痴呆检测达成销售合作协议。根据协议，希森美康将在特定区域独家销售富士瑞必欧的Lumipulse免疫检测系统及痴呆相关检测产品。此次合作基于两家日本公司于2023年在免疫检测技术领域建立的协作关系。协议的财务及其他条款未予披露。Fujirebio富士瑞必欧是阿尔茨海默病检测领域的领先开发商，其产品包括Lumipulse G β-淀粉样蛋白比率检测以及Lumipulse G pTau217/β-淀粉样蛋白1-42血浆比率检测。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260207151144a4875ac1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260207151144a4875ac1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4132","BK4170","FUJIY","AD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609432256","title":"釋放pipeline in a drug潛力 NLRP3能否催生下一個「藥王」?","url":"https://stock-news.laohu8.com/highlight/detail?id=2609432256","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609432256?lang=zh_tw&edition=fundamental","pubTime":"2026-02-05 16:35","pubTimestamp":1770280559,"startTime":"0","endTime":"0","summary":"近期，英硅智能(03696)宣布提名靶向NLRP3的外周限制性抑制剂ISM5059，该候选药物具有新颖母核，由英硅智能自有Pharma.AI平台驱动设计。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20260205/20260205163220_51027.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260205/20260205163220_51027.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402047.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["AD","BBB","IBD","PD","LU1169590202.USD","CNS","BK4135","LU1169589451.USD","BK4132","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608847042","title":"美國OTC市場Leddartech Holdings Inc.盤中異動 大幅上漲18.18%報0.003美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608847042","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608847042?lang=zh_tw&edition=fundamental","pubTime":"2026-02-03 05:07","pubTimestamp":1770066420,"startTime":"0","endTime":"0","summary":"北京时间2026年02月03日05时07分，美国OTC市场Leddartech Holdings Inc.股票出现波动，股价急速上涨18.18%。截至发稿，该股报0.003美元/股，成交量1105股，换手率0.00%，振幅0.00%。美国OTC市场Leddartech Holdings Inc.股票所在的软件服务行业中，整体跌幅为1.08%。美国OTC市场Leddartech Holdings Inc.公司简介：LeddarTech Holdings Inc 是一家开发和提供全面感知软件解决方案的公司，旨在支持高级驾驶辅助系统和自动驾驶应用的部署。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203050701a6cb79f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203050701a6cb79f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LDTCF","BK4132","AD","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129776688","title":"Digitus集團關聯公司簽署1110萬第納爾銀行融資協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1129776688","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129776688?lang=zh_tw&edition=fundamental","pubTime":"2026-01-29 16:13","pubTimestamp":1769674384,"startTime":"0","endTime":"0","summary":"迪吉特斯数字基础设施、数据中心与通信集团宣布，其关联公司已签署总额达1110万科威特第纳尔的银行融资协议。该笔融资将专项用于支持集团在科威特地区的数据中心项目建设。\n根据协议条款，银行融资将覆盖数据中心项目从土地购置到设备安装的全周期资金需求。此次融资合作标志着迪吉特斯集团在中东数字基建领域迈出关键一步，也将为科威特数字化转型注入新动力。\n（根据公开信息整理）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AD","TDS","BK4132"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":57,"code":"91000000","status":"200"}]}}